These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12106599)

  • 1. Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.
    Eckler JR; Doat MM; Rabin RA; Winter JC
    Life Sci; 2002 Aug; 71(11):1341-7. PubMed ID: 12106599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.
    Winter JC; Eckler JR; Doat MM; Rabin RA
    Pharmacol Biochem Behav; 2002 Dec; 74(1):95-101. PubMed ID: 12376156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.
    Eckler JR; Reissig CJ; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2004 Sep; 79(1):25-30. PubMed ID: 15388280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC; Helsley S; Fiorella D; Rabin RA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.
    Winter JC; Eckler JR; Rice KC; Rabin RA
    Pharmacol Biochem Behav; 2005 Jul; 81(3):694-700. PubMed ID: 15970314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.
    Winter JC; Doat M; Rabin RA
    Life Sci; 2000 Dec; 68(3):337-44. PubMed ID: 11191649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 8-hydroxy-2-(N,N-di-n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats.
    Khorana N; Young R; Glennon RA
    Pharmacol Biochem Behav; 2009 Jan; 91(3):385-92. PubMed ID: 18778728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.
    Doat-Meyerhoefer MM; Hard R; Winter JC; Rabin RA
    Pharmacol Biochem Behav; 2005 Aug; 81(4):750-7. PubMed ID: 15972234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Eckler JR; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further investigations of the interactions of antipsychotics with the (-)2,5-dimethoxy-4-methylamphetamine (DOM) discriminative stimulus.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Neuropharmacology; 1997 Oct; 36(10):1463-9. PubMed ID: 9423935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram enhances cocaine's subjective effects in rats.
    Soto PL; Hiranita T; Katz JL
    Behav Pharmacol; 2009 Dec; 20(8):759-62. PubMed ID: 20195220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic treatment with clozapine and haloperidol on stimulus control by DOM.
    Doat MM; Rabin RA; Winter JC
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):153-8. PubMed ID: 12135540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1998 Mar; 345(1):35-9. PubMed ID: 9593591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.
    Doat MM; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 Feb; 74(3):713-21. PubMed ID: 12543238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats.
    Millan MJ; Girardon S; Dekeyne A
    Psychopharmacology (Berl); 1999 Mar; 142(4):432-4. PubMed ID: 10229070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
    Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
    Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1998 Jul; 138(1):67-75. PubMed ID: 9694528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.